700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Review Article Open Access
De novo drug design is an iterative process in which the three-dimensional structure of the receptor is used to design newer molecules. It involves structure determination of the lead target complexes and the design of lead modifications using molecular modeling tools. It can also be used to design new chemical classes of compounds that present similar substituents to the target using a template or scaffold, which is chemically distinct from previously characterized leads.
To read the full article Peer-reviewed Article PDF
Author(s): Sanmati K Jain Avantika Agrawal